Logo-ajpr
Submitted: 24 Sep 2020
Accepted: 06 Oct 2020
ePublished: 30 Dec 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Avicenna J Pharm Res. 2020;1(2): 87-90.
doi: 10.34172/ajpr.2020.16
  Abstract View: 148
  PDF Download: 165

Mini Review

Potential Antiviral Drug Intervention for Treatment of COVID-19: A Minireview

Davoud Ahmadimoghaddam 1 ORCID logo, Zohreh Izadidastenaei 2* ORCID logo

1 Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding author: Zohreh Izadidastenaei, Department of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Tel: 0098-2188202508, Email: zohreizadi@sbmu.ac.ir

Abstract

In this minireview, we evaluated the studies that underlie the usage and suggestion of antivirals for the treatment of coronavirus disease 2019 (COVID-19). Until now, there has been no known curative treatment for COVID-19. However, many clinical trials have used antiviral medicines including remdesivir, lopinavir (LPV), ritonavir (RTV), ribavirin, favipiravir (FPV), oseltamivir, umifenovir, and nitazoxanide. Using remdesivir in patients with severe COVID-19 has improved respiratory symptoms, making the remdesivir one of the specific drugs suggested for the treatment of severe COVID-19. It has been shown that triple antiviral therapy (LPV, RTV, and ribavirin) can improve symptoms and consequently shorten the duration of viral shedding and hospital stay. However, the results of treatment with oseltamivir, umifenovir, and a combination of LPV and RTV were not different from the results of treatment with standard care in the time to clinical improvement. FPV showed better therapeutic responses to COVID-19 in terms of disease progression and viral clearance. Future clinical studies should evaluate the effect of antiviral agents for the treatment of COVID-19 outbreak. Therefore, it is suggested that highly active antiviral drugs should be used in combination with other therapeutic approaches for the treatment of COVID-19.
Keywords: COVID-19, Antiviral, Remdesivir, Favipiravir, Oseltamivir

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 148

Your browser does not support the canvas element.


PDF Download: 165

Your browser does not support the canvas element.